IP Library Granted Patent US 7,803,131
Granted Patent B2
US 7,803,131 · App. 11/318,058 · Granted Sep 28, 2010

Devices and methods for percutaneously treating aortic valve stenosis

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,803,131
App. No.
11/318,058
Granted
Sep 28, 2010
Kind
B2
Abstract

Devices and methods for their use in percutaneously increasing the aortic valve flow of a stenotic aortic valve are provided. The subject devices include an aortic valve isolation element, a shunt element and an aortic valve flushing element. Also provided are systems and kits that include the subject devices and can be employed in practicing the subject methods. The subject devices, methods, systems and kits find use in treating conditions associated with the presence of stenotic aortic valves.

Claims (6)

1. A device comprising: (a) a valve isolation element that includes: (i) a ventricular side aortic valve occlusion element configured to prevent fluid flow from the valve to the ascending aorta, the ventricular side aortic valve occlusion element comprising a funnel structure, the funnel structure including a self-expanding ring and a thin membrane impervious to fluid flow; and (ii) an ascending aorta occlusion element, the occlusion element including an occlusion bell comprising an expandable wire scaffold; (b) a shunt element having first and second ends and configured to provide blood flow through a region of isolation proximate the aortic valve, the funnel structure being positioned at a distal end of the shunt to anchor the device in place, the shunt element passing through the central regions of the ventricular side aortic valve occlusion element and the ascending aorta occlusion element and having at least one inflow port and at least one outflow port with a one way valve; and (c) an aortic valve flushing element comprising a dissolution fluid introduction element and an aspiration element configured to maintain the volume and pressure around the valve substantially constant.

2. The device according to claim 1 , wherein said fluid introducing element is in fluid communication with a source of stenotic dissolution fluid.

3. The device according to claim 2 , wherein said stenotic dissolution fluid is an acidic dissolution fluid.

4. The device according to claim 1 , wherein said device further includes a fluid flow diverter element.

5. The device according to claim 1 , wherein said device is configured for percutaneous delivery to a target site.

6. The device according to claim 1 , wherein said device further comprises an integrated introducer.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2025
From: CARDINAL HEALTH SWITZERLAND 515 GMBH; CARDINAL HEALTH 529, LLC; CORDIS CORPORATION; FLEXIBLE STENTING SOLUTIONS, INC
To: CORDIS US CORP
Reel/Frame 072987/0675 →
SECURITY INTEREST Recorded Oct 1, 2025
From: CORDIS US CORP.; ACCESS CLOSURE, LLC
To: HPS INVESTMENT PARTNERS, LLC
Reel/Frame 072973/0157 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2017
From: CORDIS CORPORATION
To: CARDINAL HEALTH SWITZERLAND 515 GMBH
Reel/Frame 042126/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 6, 2008
From: CORAZON TECHNOLOGIES, INC.
To: CORDIS CORPORATION
Reel/Frame 020609/0277 →